AXEVIL Capital

Spring Health Stock Price, Valuation & IPO

Private company — Spring Health is privately held. Its shares are not listed on any public exchange and can only be accessed through private secondary transactions.

Status source: AXEVIL investment team

$50.23 per share (AXEVIL consensus estimate)

Source: AXEVIL consensus of recent secondary transactions · as of 17 November 2026

Last round valuation: $3.5B

Source: D Aegis, April 2026, post-money

Total raised: $465+M

Data last updated: 17 November 2026

About Spring Health

Spring Health was founded in 2016 in New York by Yale graduates April Koh and Adam Chekroud. In graduate school, Chekroud built a model that predicts, based on a questionnaire, whether an antidepressant will help a patient, and this approach formed the basis of treatment selection. The company sells psychological help as a benefit: the employer or insurer pays, and the employee and their family receive therapy, a psychiatrist, coaching, and digital programs in one application. Less than two days pass until the first meeting with a specialist, compared to 48 days for typical assistance programs; 92% of participants with depression or anxiety significantly improve their condition, and employer costs for mental health insurance claims fall by half. In May 2026, Alma was acquired — a network of independent psychotherapists with contracts with major insurers, adding 120 million insured individuals. Revenue grew by an average of 80%+ per year for three years. A total of more than $465 million has been raised, with a valuation of $3.3 billion.

  • Sector: Health & Pharma

Key highlights

  1. California: 245 thousand government employees. In July 2026, the state HR agency CalHR transferred an employee assistance program for 153 agencies and their families to Spring Health. The company promises appointments in less than two days on average.
  2. Highmark: visit in three days. An insurer from Pennsylvania launched service for clients in Pennsylvania, Delaware, New York, and West Virginia starting January 2024. According to Highmark, access to assistance has increased by 40%.
  3. Alma: 120 million insured. The acquisition closed on May 1, 2026, and added a network of therapists with contracts with national insurers. Alma remained a separate brand led by founder Harry Ritter.

Funding rounds

DateRoundPrice / sharePost-money valuation
30 April 2026D Aegis$69.22$3.5B
31 July 2024E$67.87$3.3B
12 April 2023D$54.85$2.5B
16 September 2021C$45.90$2B
20 November 2020A-2$2.86$86M
27 January 2020A-1$1.43$30M

Frequently asked questions

How can I buy Spring Health stock before the IPO?

Not on a public exchange — Spring Health is privately held. Shares change hands only in private secondary transactions. AXEVIL structures those as dedicated US special purpose vehicles for accredited investors, subject to availability and to the rules of your jurisdiction.

What is the Spring Health stock price?

A private company has no single official share price. AXEVIL's consensus estimate is $50.23 per share as of 17 November 2026. Its most recent round implied a post-money valuation of $3.5B (April 2026).

What is Spring Health's valuation (net worth)?

Spring Health's most recent funding round valued the company at $3.5B post-money (April 2026) — the latest primary-market measure of what the company is worth. Secondary trades can price its shares above or below that round.

When will Spring Health IPO?

No listing has been announced. AXEVIL does not forecast IPO dates — this page states what has actually been filed or reported, with the date it was last checked.

Is Spring Health publicly traded?

No. Spring Health is a private company and its shares are not listed on any public exchange.

Does Spring Health have a stock symbol?

No. Spring Health has no ticker symbol because its shares are not listed on any exchange; a symbol is assigned only at an IPO or direct listing.

Similar companies

Risk disclosure

Nothing on this page is an offer to sell or a solicitation to buy any security, and it is not investment advice. Valuations and share prices shown here are AXEVIL estimates built from primary sources — filings, announced rounds and completed secondary transactions — not quoted market prices, and they can be revised. Private-company shares are illiquid, may be impossible to sell, and the entire amount invested can be lost. Availability depends on your jurisdiction and on accredited-investor status.

Full legal disclosures · All companies